A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital

Absract Background To describe the course and intervention of an hospital-wide IMI-Producing Enterobacter ludwigii outbreak. Methods This was an outbreak interventional study, done at a tertiary care center in Tel-Aviv, Israel. Data was collected on the course of the outbreak and the demographic and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vered Schechner, Katya Levytskyi, Ohad Shalom, Alexander Yalek, Amos Adler
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
IMI
Acceso en línea:https://doaj.org/article/ad9d7e5985294d8c91921b60fcca024a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ad9d7e5985294d8c91921b60fcca024a
record_format dspace
spelling oai:doaj.org-article:ad9d7e5985294d8c91921b60fcca024a2021-12-05T12:24:05ZA hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital10.1186/s13756-021-01036-02047-2994https://doaj.org/article/ad9d7e5985294d8c91921b60fcca024a2021-11-01T00:00:00Zhttps://doi.org/10.1186/s13756-021-01036-0https://doaj.org/toc/2047-2994Absract Background To describe the course and intervention of an hospital-wide IMI-Producing Enterobacter ludwigii outbreak. Methods This was an outbreak interventional study, done at a tertiary care center in Tel-Aviv, Israel. Data was collected on the course of the outbreak and the demographic and clinical characteristics of all patients involved in the outbreak. The intervention measures included patients’ cohorting, contact isolation precautions, environmental cleaning and screening of contacts. The molecular features and phylogeny of outbreak-related isolates were studied by whole-genome based analysis. Results The outbreak included 34 patients that were colonized by IMI-Producing E. ludwigii and were identified in 24 wards throughout the hospital. Colonization was identified in the first 72 h of admission in 13/34 patients (38.2%). Most patients (91.2%) were admitted from home and had relatively low level of comorbidities. The majority of them (88%) had no recent use of invasive catheters and none had previous carriage of other multi-drug resistant bacteria. All available isolates harbored the bla IMI-17 allele and belonged to Sequence-Type 385. With the exception of two isolates, all isolates were closely related with less than a 20-SNP difference between them. Conclusions This outbreak had most likely originated in the community and subsequently disseminated inside our institution. More studies are required in order to elucidate the epidemiology of IMI-Producing E. ludwigii and the possible role of environmental sources in its dissemination.Vered SchechnerKatya LevytskyiOhad ShalomAlexander YalekAmos AdlerBMCarticleIMIOutbreakCarbapenemaseInfectious and parasitic diseasesRC109-216ENAntimicrobial Resistance and Infection Control, Vol 10, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic IMI
Outbreak
Carbapenemase
Infectious and parasitic diseases
RC109-216
spellingShingle IMI
Outbreak
Carbapenemase
Infectious and parasitic diseases
RC109-216
Vered Schechner
Katya Levytskyi
Ohad Shalom
Alexander Yalek
Amos Adler
A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital
description Absract Background To describe the course and intervention of an hospital-wide IMI-Producing Enterobacter ludwigii outbreak. Methods This was an outbreak interventional study, done at a tertiary care center in Tel-Aviv, Israel. Data was collected on the course of the outbreak and the demographic and clinical characteristics of all patients involved in the outbreak. The intervention measures included patients’ cohorting, contact isolation precautions, environmental cleaning and screening of contacts. The molecular features and phylogeny of outbreak-related isolates were studied by whole-genome based analysis. Results The outbreak included 34 patients that were colonized by IMI-Producing E. ludwigii and were identified in 24 wards throughout the hospital. Colonization was identified in the first 72 h of admission in 13/34 patients (38.2%). Most patients (91.2%) were admitted from home and had relatively low level of comorbidities. The majority of them (88%) had no recent use of invasive catheters and none had previous carriage of other multi-drug resistant bacteria. All available isolates harbored the bla IMI-17 allele and belonged to Sequence-Type 385. With the exception of two isolates, all isolates were closely related with less than a 20-SNP difference between them. Conclusions This outbreak had most likely originated in the community and subsequently disseminated inside our institution. More studies are required in order to elucidate the epidemiology of IMI-Producing E. ludwigii and the possible role of environmental sources in its dissemination.
format article
author Vered Schechner
Katya Levytskyi
Ohad Shalom
Alexander Yalek
Amos Adler
author_facet Vered Schechner
Katya Levytskyi
Ohad Shalom
Alexander Yalek
Amos Adler
author_sort Vered Schechner
title A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital
title_short A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital
title_full A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital
title_fullStr A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital
title_full_unstemmed A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital
title_sort hospital-wide outbreak of imi-17-producing enterobacter ludwigii in an israeli hospital
publisher BMC
publishDate 2021
url https://doaj.org/article/ad9d7e5985294d8c91921b60fcca024a
work_keys_str_mv AT veredschechner ahospitalwideoutbreakofimi17producingenterobacterludwigiiinanisraelihospital
AT katyalevytskyi ahospitalwideoutbreakofimi17producingenterobacterludwigiiinanisraelihospital
AT ohadshalom ahospitalwideoutbreakofimi17producingenterobacterludwigiiinanisraelihospital
AT alexanderyalek ahospitalwideoutbreakofimi17producingenterobacterludwigiiinanisraelihospital
AT amosadler ahospitalwideoutbreakofimi17producingenterobacterludwigiiinanisraelihospital
AT veredschechner hospitalwideoutbreakofimi17producingenterobacterludwigiiinanisraelihospital
AT katyalevytskyi hospitalwideoutbreakofimi17producingenterobacterludwigiiinanisraelihospital
AT ohadshalom hospitalwideoutbreakofimi17producingenterobacterludwigiiinanisraelihospital
AT alexanderyalek hospitalwideoutbreakofimi17producingenterobacterludwigiiinanisraelihospital
AT amosadler hospitalwideoutbreakofimi17producingenterobacterludwigiiinanisraelihospital
_version_ 1718371978363011072